Although protein kinase inhibitors are mostly used in cancer therapy, e.g., for the treatment of chronic myeloid leukemia or melanoma, they are now being increasingly explored for the treatment of non-oncological conditions, including schistosomiasis. The gene discussed is WEE1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.